- Home
- LKCO vs SNPX Comparison
LKCO vs SNPX Comparison
Compare LKCO & SNPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LKCO
- SNPX
- Stock Information
- Founded
- LKCO 2009
- SNPX 2012
- Country
- LKCO China
- SNPX United States
- Employees
- LKCO N/A
- SNPX N/A
- Industry
- LKCO EDP Services
- SNPX Medicinal Chemicals and Botanical Products
- Sector
- LKCO Technology
- SNPX Health Care
- Exchange
- LKCO Nasdaq
- SNPX Nasdaq
- Market Cap
- LKCO 4.3M
- SNPX 4.1M
- IPO Year
- LKCO N/A
- SNPX N/A
- Fundamental
- Price
- LKCO $2.13
- SNPX $3.11
- Analyst Decision
- LKCO
- SNPX Strong Buy
- Analyst Count
- LKCO 0
- SNPX 1
- Target Price
- LKCO N/A
- SNPX $14.00
- AVG Volume (30 Days)
- LKCO 102.4K
- SNPX 28.1K
- Earning Date
- LKCO 01-01-0001
- SNPX 11-12-2024
- Dividend Yield
- LKCO N/A
- SNPX N/A
- EPS Growth
- LKCO N/A
- SNPX N/A
- EPS
- LKCO N/A
- SNPX N/A
- Revenue
- LKCO $36,982,661.00
- SNPX N/A
- Revenue This Year
- LKCO N/A
- SNPX N/A
- Revenue Next Year
- LKCO N/A
- SNPX N/A
- P/E Ratio
- LKCO N/A
- SNPX N/A
- Revenue Growth
- LKCO N/A
- SNPX N/A
- 52 Week Low
- LKCO $1.75
- SNPX $2.72
- 52 Week High
- LKCO $8.00
- SNPX $8.78
- Technical
- Relative Strength Index (RSI)
- LKCO 36.75
- SNPX 49.67
- Support Level
- LKCO $1.75
- SNPX $2.82
- Resistance Level
- LKCO $2.21
- SNPX $3.42
- Average True Range (ATR)
- LKCO 0.35
- SNPX 0.24
- MACD
- LKCO 0.02
- SNPX 0.05
- Stochastic Oscillator
- LKCO 20.54
- SNPX 52.79
About LKCO Luokung Technology Corp
Luokung Technology Corp is a spatial-temporal intelligent big data services company, as well as a provider of LBS for various industries in China. It has established city-level and industry-level holographic spatial-temporal digital twin systems and actively serves industries including smart transportation (autonomous driving, smart highway and vehicle-road collaboration), natural resource asset management (carbon neutral and environmental protection remote sensing data service), and LBS smart industry applications (mobile Internet LBS, smart travel, smart logistics, new infrastructure, smart cities, emergency rescue, among others).
About SNPX Synaptogenix Inc.
Synaptogenix Inc is a biopharmaceutical company with product candidates in pre-clinical and clinical development. It is principally focused on developing a product platform based upon a drug candidate called bryostatin for the treatment of Alzheimer's disease, which is in the clinical testing stage. It is also evaluating bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as Fragile X syndrome, Multiple Sclerosis, and Niemann-Pick Type C disease, which have undergone pre-clinical testing.